This announcement is a separate document:
Aileron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.